Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.
Ethiodized oil
Hepatocellular carcinoma
Liver
Transarterial chemoembolization
Treatment response
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
06 Nov 2023
06 Nov 2023
Historique:
received:
24
05
2023
accepted:
20
08
2023
revised:
10
08
2023
medline:
6
11
2023
pubmed:
6
11
2023
entrez:
6
11
2023
Statut:
aheadofprint
Résumé
Conventional transarterial chemoembolization (cTACE) utilizing ethiodized oil as a chemotherapy carrier has become a standard treatment for intermediate-stage hepatocellular carcinoma (HCC) and has been adopted as a bridging and downstaging therapy for liver transplantation. Water-in-oil emulsion made up of ethiodized oil and chemotherapy solution is retained in tumor vasculature resulting in high tissue drug concentration and low systemic chemotherapy doses. The density and distribution pattern of ethiodized oil within the tumor on post-treatment imaging are predictive of the extent of tumor necrosis and duration of response to treatment. This review describes the multiple roles of ethiodized oil, particularly in its role as a biomarker of tumor response to cTACE. CLINICAL RELEVANCE: With the increasing complexity of locoregional therapy options, including the use of combination therapies, treatment response assessment has become challenging; Ethiodized oil deposition patterns can serve as an imaging biomarker for the prediction of treatment response, and perhaps predict post-treatment prognosis. KEY POINTS: • Treatment response assessment after locoregional therapy to hepatocellular carcinoma is fraught with multiple challenges given the varied post-treatment imaging appearance. • Ethiodized oil is unique in that its' radiopacity can serve as an imaging biomarker to help predict treatment response. • The pattern of deposition of ethiodozed oil has served as a mechanism to detect portions of tumor that are undertreated and can serve as an adjunct to enhancement in order to improve management in patients treated with intraarterial embolization with ethiodized oil.
Identifiants
pubmed: 37930412
doi: 10.1007/s00330-023-10326-7
pii: 10.1007/s00330-023-10326-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68(2):723–750
pubmed: 29624699
doi: 10.1002/hep.29913
Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27(9):1485
pubmed: 19224838
pmcid: 2668555
doi: 10.1200/JCO.2008.20.7753
Molla N, AlMenieir N, Simoneau E et al (2014) The role of interventional radiology in the management of hepatocellular carcinoma. Curr Oncol 21(3):480–492
doi: 10.3747/co.21.1829
Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67(1):358–380
pubmed: 28130846
doi: 10.1002/hep.29086
de Baere T, Arai Y, Lencioni R et al (2016) Treatment of liver tumors with lipiodol TACE: technical recommendations from experts opinion. Cardiovasc Intervent Radiol 39(3):334–343
pubmed: 26390875
doi: 10.1007/s00270-015-1208-y
Miyayama S, Mitsui T, Zen Y et al (2009) Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatol Res 39(4):374–381
pubmed: 19054146
doi: 10.1111/j.1872-034X.2008.00465.x
Miyayama S, Matsui O, Yamashiro M et al (2007) Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 18(3):365–376
pubmed: 17377182
doi: 10.1016/j.jvir.2006.12.004
Iwazawa J, Ohue S, Kitayama T, Sassa S, Mitani T (2011) C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 197(2):W337–W342
Miyayama S, Yamashiro M, Hashimoto M et al (2014) Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma≤ 6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography. Cardiovasc Intervent Radiol 37(2):388–395
pubmed: 23775550
doi: 10.1007/s00270-013-0667-2
Aslam A, Do RKG, Kambadakone A et al (2020) Hepatocellular carcinoma liver imaging reporting and data systems treatment response assessment: Lessons learned and future directions. World J Hepatol 12(10):738
pubmed: 33200013
pmcid: 7643220
doi: 10.4254/wjh.v12.i10.738
Vossen JA, Buijs M, Kamel IR (2006) Assessment of tumor response on MR imaging after locoregional therapy. Tech Vasc Interv Radiol 9(3):125–132
pubmed: 17561215
doi: 10.1053/j.tvir.2007.02.004
Mendiratta-Lala M, Masch WR, Shampain K et al (2020) MRI assessment of hepatocellular carcinoma after local-regional therapy: a comprehensive review. Radiol Imaging Cancer 2(1):e190024
Chiu RY, Yap WW, Patel R, Liu D, Klass D, Harris AC (2016) Hepatocellular carcinoma post embolotherapy: imaging appearances and pitfalls on computed tomography and magnetic resonance imaging. Can Assoc Radiol J 67(2):158–172
pubmed: 26961737
doi: 10.1016/j.carj.2015.09.006
Agnello F, Salvaggio G, Cabibbo G et al (2013) Imaging appearance of treated hepatocellular carcinoma. World J Hepatol 5(8):417
pubmed: 24023980
pmcid: 3767840
doi: 10.4254/wjh.v5.i8.417
Matsui O, Takashima T, Kadoya M et al (1987) Mechanism of Lipiodol accumulation and retention in hepatic tumors. Analysis in cases with simple Lipiodol injection. Nihon Igaku Hoshasen Gakkai Zasshi 47:1395–140
Ohishi H, Uchida H, Yoshimura H et al (1985) Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154(1):25-9
Imaeda T, Yamawaki Y, Seki M et al (1993) Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol 16(4):209–213
pubmed: 8402781
doi: 10.1007/BF02602962
Takayasu K, Arii S, Matsuo N et al (2000) Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol 175(3):699–704
Miszczuk MA, Chapiro J, Geschwind JH et al (2020) Lipiodol as an imaging biomarker of tumor response after conventional transarterial chemoembolization: prospective clinical validation in patients with primary and secondary liver cancer. Transl Oncol 13(3):100742
pubmed: 32092672
pmcid: 7036424
doi: 10.1016/j.tranon.2020.01.003
Vogl TJ, Trapp M, Schroeder H et al (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success—results from a liver transplantation center. Radiology 214(2):349–357
pubmed: 10671580
doi: 10.1148/radiology.214.2.r00fe06349
Chen C-S, Li F-K, Guo C-Y et al (2016) Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Oncotarget 7(6):7241
Matsui Y, Horikawa M, Noudeh YJ, Kaufman JA, Kolbeck KJ, Farsad K (2017) Baseline tumor Lipiodol uptake after transarterial chemoembolization for hepatocellular carcinoma: identification of a threshold value predicting tumor recurrence. Radiol Oncol 51(4):393–400
pubmed: 29333117
pmcid: 5765315
doi: 10.1515/raon-2017-0030
Dioguardi Burgio M, Ronot M, Bruno O et al (2016) Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation. Liver Transpl 22(11):1491–1500
doi: 10.1002/lt.24615
Dioguardi Burgio M, Sartoris R, Libotean C et al (2019) Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response. Cancer Imaging 19(1):1–9
Kim D, Ryu H, Choi J et al (2012) Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma. Aliment Pharmacol Ther 35(11):1343–1350
pubmed: 22486716
doi: 10.1111/j.1365-2036.2012.05089.x
Charoenvisal C, Tanaka T, Nishiofuku H et al (2021) Feasibility and techniques of securing 3D-safety margin in superselective transarterial chemoembolization to improve local tumor control for small hepatocellular carcinoma: an intend-to-treat analysis. Liver Cancer 10(1):63–71
pubmed: 33708640
pmcid: 7923884
doi: 10.1159/000512337
Ueda K, Matsui O, Kawamori Y et al (1998) Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology 206(1):161–166
pubmed: 9423667
doi: 10.1148/radiology.206.1.9423667
Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y (2009) Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography—radiologic-pathologic correlation. Radiology 252(2):605–614
pubmed: 19703890
doi: 10.1148/radiol.2522081414
Miyayama S, Yamashiro M, Okuda M et al (2011) Detection of corona enhancement of hypervascular hepatocellular carcinoma by C-arm dual-phase cone-beam CT during hepatic arteriography. Cardiovasc Intervent Radiol 34(1):81–86
pubmed: 20333382
doi: 10.1007/s00270-010-9835-9
Sakon M, Nagano H, Nakamori S et al (2002) Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg 137(1):94–99
pubmed: 11772225
doi: 10.1001/archsurg.137.1.94
Terayama N, Matsui O, Gabata T et al (2001) Accumulation of iodized oil within the non-neoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization. Cardiovasc Intervent Radiol 24(6):383–387
pubmed: 11907744
doi: 10.1007/s00270-001-0070-2
Kattipatanapong T, Nishiofuku H, Tanaka T et al (2020) Improved local tumor control and survival rates by obtaining a 3D-safety margin in superselective transarterial chemoembolization for small hepatocellular carcinoma. Cardiovasc Intervent Radiol 43(3):423–433
pubmed: 31720806
doi: 10.1007/s00270-019-02365-9
Miyayama S, Yamashiro M, Sugimori N, Ikeda R, Okimura K, Sakuragawa N (2019) Outcomes of patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization using guidance software. J Vasc Interv Radiol 30(1):10–18
pubmed: 30580809
doi: 10.1016/j.jvir.2018.08.009
Ikeda M, Arai Y, Inaba Y et al (2022) Conventional or drug-eluting beads? Randomized controlled study of chemoembolization for hepatocellular carcinoma: JIVROSG-1302. Liver Cancer 11(5):440-450
Takayasu K, Moriyama N, Muramatsu Y et al (1984) Hepatic arterial embolization for hepatocellular carcinoma. Comparison of CT scans and resected specimens. Radiology 150(3):661–5
Herber S, Biesterfeld S, Franz U et al (2008) Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol 31(4):768–777
pubmed: 18196335
doi: 10.1007/s00270-007-9270-8
Choi BI, Kim HC, Han JK et al (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182(3):709–713
pubmed: 1311116
doi: 10.1148/radiology.182.3.1311116
Riaz A, Lewandowski RJ, Kulik L et al (2010) Radiologic–pathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol 33(6):1143–1152
pubmed: 19967371
doi: 10.1007/s00270-009-9766-5
Kwan SW, Fidelman N, Ma E, Kerlan RK Jr, Yao FY (2012) Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl 18(6):727–736
pubmed: 22344899
pmcid: 4161220
doi: 10.1002/lt.23413
Galbán CJ, Chenevert TL, Meyer CR et al (2009) The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med 15(5):572–576
pubmed: 19377487
pmcid: 3307223
doi: 10.1038/nm.1919
Choi SJ, Kim J, Seo J, Kim HS, Lee JM, Park H (2014) Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Abdom Imaging 39(3):518–525
pubmed: 24519566
doi: 10.1007/s00261-014-0087-z
Hinrichs JB, Shin HO, Kaercher D et al (2016) Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE. Eur Radiol 26(10):3447–3455
pubmed: 26769666
doi: 10.1007/s00330-015-4203-4
Choi SJ, Kim J, Seo J, Kim HS, Lee JM, Park H (2016) Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization. Eur Radiol 26(1):225–234
pubmed: 25991485
doi: 10.1007/s00330-015-3825-x
Choi SJ, Kim J, Kim HS, Park H (2017) Parametric response mapping of dynamic CT: enhanced prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Abdom Radiol 42(7):1871–1879
Hucke F, Pinter M, Graziadei I et al (2014) How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma. J Hepatol 61(6):1287–1296
pubmed: 25016222
doi: 10.1016/j.jhep.2014.07.002
Ha Y, Han S, Shim JH et al (2015) Nomograms for predicting outcomes after chemoembolization in patients with nonmetastatic hepatocellular carcinoma. J Vasc Interv Radiol 26(8):1093101. e1
Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5(1):1–9
Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48(4):441–446
pubmed: 22257792
pmcid: 4533986
doi: 10.1016/j.ejca.2011.11.036
Parmar C, Grossmann P, Bussink J, Lambin P, Aerts HJJSr, (2015) Machine learning methods for quantitative radiomic biomarkers. Sci Rep 5(1):1–11
doi: 10.1038/srep13087
Sun Y, Bai H, Xia W et al (2020) Predicting the outcome of transcatheter arterial embolization therapy for unresectable hepatocellular carcinoma based on radiomics of preoperative multiparameter MRI. J Magn Reson Imaging 52(4):1083–1090
pubmed: 32233054
doi: 10.1002/jmri.27143
Liu Q-P, Yang K-L, Xu X, Liu X-S, Qu J-R, Zhang Y-DJAR (2022) Radiomics analysis of pretreatment MRI in predicting tumor response and outcome in hepatocellular carcinoma with transarterial chemoembolization: a two-center collaborative study. Abdom Radiol 47(2):651–663
doi: 10.1007/s00261-021-03375-3
Dong Z, Lin Y, Lin F et al (2021) Prediction of early treatment response to initial conventional transarterial chemoembolization therapy for hepatocellular carcinoma by machine-learning model based on computed tomography. J Hepatocell Carcinoma 8:1473–1484
pubmed: 34877267
pmcid: 8643205
doi: 10.2147/JHC.S334674
Ivanics T, Salinas-Miranda E, Abreu P et al (2021) A pre-TACE radiomics model to predict HCC progression and recurrence in liver transplantation: a pilot study on a novel biomarker. Transplant 105(11):2435–2444
doi: 10.1097/TP.0000000000003605
Li L, Kan X, Zhao Y et al (2021) Radiomics Signature: a potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma. Int J Med Sci 18(11):2276–2284
pubmed: 33967603
pmcid: 8100633
doi: 10.7150/ijms.55510
Guo Z, Zhong N, Xu X et al (2021) Prediction of hepatocellular carcinoma response to transcatheter arterial chemoembolization: a real-world study based on non-contrast computed tomography radiomics and general image features. J Hepatocell Carcinoma 8:773–782
Pan M, Tang Z, Fu S et al eds (2021) Deep learning-based aggressive progression prediction from CT images of hepatocellular carcinoma. Comput Aided Diag 11597
Zhang L, Xia W, Yan Z-P et al (2020) Deep learning predicts overall survival of patients with unresectable hepatocellular carcinoma treated by transarterial chemoembolization plus sorafenib. Front Oncol 10:593292
Liu Q-P, Xu X, Zhu F-P, Zhang Y-D, Liu X-SJE (2020) Prediction of prognostic risk factors in hepatocellular carcinoma with transarterial chemoembolization using multi-modal multi-task deep learning. E Clin Med 23:100379
Tian Y, Komolafe TE, Chen T, Zhou B, Yang XJJoM (2022) Engineering B. Prediction of TACE treatment response in a preoperative MRI via analysis of integrating deep learning and radiomics features. J Med Biol Eng 42(2):169-178
Peng J, Huang J, Zhang JJFio (2021) Predicting the initial treatment response to transarterial chemoembolization in intermediate-stage hepatocellular carcinoma by the integration of radiomics and deep learning. Front Oncol 11:730282
Li Y, Xu Z, An C, Chen H, Li XJJoPM (2022) Multi-task deep learning approach for simultaneous objective response prediction and tumor segmentation in HCC patients with transarterial chemoembolization. J Pers Med 12(2):248
Zhang L, Jiang Y, Jin Z et al (2022) Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos. Cancer imaging 22(1):1–14
doi: 10.1186/s40644-022-00457-3